174 related articles for article (PubMed ID: 8419938)
1. Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus.
Pincus SH; McClure J
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):332-6. PubMed ID: 8419938
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.
Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection.
Pincus SH; Fang H; Wilkinson RA; Marcotte TK; Robinson JE; Olson WC
J Immunol; 2003 Feb; 170(4):2236-41. PubMed ID: 12574398
[TBL] [Abstract][Full Text] [Related]
6. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
[TBL] [Abstract][Full Text] [Related]
7. Complement activation by human monoclonal antibodies to human immunodeficiency virus.
Spear GT; Takefman DM; Sullivan BL; Landay AL; Zolla-Pazner S
J Virol; 1993 Jan; 67(1):53-9. PubMed ID: 7677959
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
9. Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.
Maeda Y; Matsushita S; Hattori T; Murakami T; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2049-54. PubMed ID: 1493053
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of HIV-infected cells by anti-gp120 immunotoxins.
Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):193-203. PubMed ID: 2328157
[TBL] [Abstract][Full Text] [Related]
11. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943
[TBL] [Abstract][Full Text] [Related]
12. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
Moore JP; McKeating JA; Norton WA; Sattentau QJ
J Virol; 1991 Mar; 65(3):1133-40. PubMed ID: 1995942
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.
Neurath AR; Strick N; Jiang S; Li YY; Debnath AK
BMC Infect Dis; 2002 Apr; 2():6. PubMed ID: 11983022
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
[TBL] [Abstract][Full Text] [Related]
16. Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).
Flasher D; Konopka K; Chamow SM; Dazin P; Ashkenazi A; Pretzer E; Düzgünes N
Biochim Biophys Acta; 1994 Aug; 1194(1):185-96. PubMed ID: 8075135
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein.
Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J
J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562
[TBL] [Abstract][Full Text] [Related]
18. Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.
Till MA; Ghetie V; May RD; Auerbach PC; Zolla-Pazner S; Gorny MK; Gregory T; Uhr JW; Vitetta ES
J Acquir Immune Defic Syndr (1988); 1990; 3(6):609-14. PubMed ID: 2140127
[TBL] [Abstract][Full Text] [Related]
19. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Moore JP; McKeating JA; Weiss RA; Sattentau QJ
Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
